New SARS-CoV-2 Rapid...
Latest Updates on CO...
23rd November 2020 Content supplied by: various sources as indicated
Latest Updates on COVID-19 Testing - Kits, Products, Services, Instrumentation - 24 Nov 2020

This week: 'Just in time' or just too late - FDA authorizes advanced molecular test you can perform at home based on loop-mediated amplification technology; India Medical Council gets behind affordable CRISPR test that can be read on a simple paper strip; ECDC releases document on rapid antigen tests urging member nations to get validating; a promising T-cell detection method to show a previous infection with SARS-CoV-2 to be released this fall and Cytiva offers an immunoassay development service.
US FDA Authorizes First At-Home Molecular COVID-19 Test
The US FDA has authorized the first prescription COVID-19 molecular test that can be performed entirely at-home. The test fits into the palm of your hand and uses real-time LAMP technology to give a result in just 11 minutes.
Find Out More
Urgent Demand From ECDC to Validate COVID-19 Rapid Antigen Tests
The ECDC has revised its recommendations for rapid antigen testing in a new document that provides independent evaluations of several rapid antigen tests on the market along with requirements labs must adhere to.
Find Out More
New Point-of-Care Immunoassay Development Service
Cytiva (Formerly GE Healthcare) has started a new diagnostic test development and support service for point-of-care diagnostic developers to increase speed to market of new tests through infrastructure, expertise and consultation for immunoassay development.
Find Out More
Microsoft and Biotech Pair-Up to Design New T-Cell Test For SARS-CoV-2 Infection
A new clinical diagnostic test that measures the T-cell response in SARS-CoV-2 infected individuals that can provide a complete picture of the duration of immunity to the virus following an infection or administration of a vaccine will be released this fall.
Find Out More
CRISPR Dipstick Test for COVID-19 Diagnosis is Rolled Out
Tata Group has begun distributing its Feluda COVID-19 test to labs across India. The CRISPR-based test utilizes a specially adapted Cas9 protein transcription, and a result is read on a dipstick placed into the CRISPR mixture after amplification of the viral material.
Find Out More
Recombinant Version of Mink Strain Spike-Protein Available
Sino Biological has launched a recombinant Y453F RBD protein, the mutation in SARS-CoV-2 that infected mink and workers at a farm in Denmark recently. This protein adds to Sino's large collection of proteins for antibody and vaccine research.
Find Out More
Tags:
Date Published: 23rd November 2020
New SARS-CoV-2 Rapid Antigen and
Latest Updates on COVID-19 Testing